RENEO PHARMACEUTICALS INC (RPHM) Stock Balance Sheet
NASDAQ:RPHM - Nasdaq - US75974E1038 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.97M | 27.63M | 19.90M | 124.70M | 53.60M | |||
| Marketable Securities | 40.70M | 75.33M | 81.20M | 23.00M | 0.00 | |||
| Other Current Assets | 1.32M | 3.66M | 5.20M | 6.10M | 1.40M | |||
| Total Current Assets | 77.99M | 106.62M | 106.40M | 153.70M | 55.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 574.00K | 733.00K | 1.70M | 200.00K | 100.00K | |||
| Other Non-Current Assets | 153.00K | 81.00K | 100.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 727.00K | 814.00K | 1.80M | 300.00K | 200.00K | |||
| TOTAL ASSETS | 78.72M | 107.44M | 108.20M | 154.00M | 55.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.28M | 9.46M | 5.20M | 4.20M | 3.70M | |||
| Accounts Payable | 64.00K | 8.72M | 1.90M | 2.00M | 900.00K | |||
| Total Current Liabilities | 1.35M | 18.18M | 7.10M | 6.20M | 4.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 500.00K | 649.00K | 1.10M | 600.00K | 0.00 | |||
| Total Non-Current Liabilities | 500.00K | 649.00K | 1.10M | 600.00K | 0.00 | |||
| TOTAL LIABILITIES | 1.85M | 18.83M | 8.20M | 6.80M | 4.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -232.26M | -218.47M | -136.70M | -84.70M | -45.00M | |||
| Additional Paid In Capital | 309.14M | 307.07M | 236.70M | 231.90M | 2.80M | |||
| Common Shares | 3.00K | 3.00K | 0.00 | 0.00 | 92.70M | |||
| Other Shareholders' Equity | -13.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 33.42M | 33.42M | 24.70M | 24.50M | 24.20M | |||
| Tangible Book Value per Share | 2.30 | 2.65 | 4.05 | 6.01 | -1.74 | |||
| Total Shareholders' Equity | 76.87M | 88.61M | 100.00M | 147.20M | 50.60M | |||
| TOTAL LIABILITIES AND EQUITY | 78.72M | 107.44M | 108.20M | 154.00M | 55.20M | |||
| Statistics | ||||||||
| Current Ratio | 57.86 | 5.87 | 14.99 | 24.79 | 11.96 | |||
| Return On Assets (ROA) | -71.83% | -72.03% | -48.02% | -25.82% | -35.27% | |||
| Return On Equity (ROE) | -73.56% | -87.34% | -51.96% | -27.02% | -38.48% | |||
All data in USD , ROIC based on taxRate of 0.21